Market Trends– category –
-
Scalable Automation in Adherent-Cell Cultures Boosts Yield and Quality: Corning’s HYPERStack and CellCube Systems Key to Efficiency
BioProcess International USA Overview Automation in scaling out adherent cell cultures significantly enhances consistency, proving especially effective where labor and bioprocessing expertise are limited. Automated culture platforms impr... -
Cell & Gene Therapy Manufacturing Faces Deepening Bottlenecks: AmplifyBio, Exothera Close; Thermo Fisher Cuts Viral Vector Jobs, but FDA Eases Regulations to Support Growth
Endpoints News Global Overview Despite cell and gene therapies becoming a commercial reality, manufacturing remains the primary bottleneck. The CDMO sector is struggling with overcapacity and underfunding, leading to closures like Amplif... -
Catalent Bolsters End-to-End CDMO Services for Autologous & Allogeneic Cell Therapies, Including iPSC Center of Excellence
Catalent USA Overview Catalent is enhancing its end-to-end CDMO manufacturing support and process development services for both autologous and allogeneic cell therapies, covering CAR-T, TCR, TIL, NK cells, and iPSC- and MSC-derived treat... -
All G Unveils Bovine-Free Lactoferrin in U.S. via Precision Fermentation, Establishing Multi-Ton Annual Production Capacity
foodnavigator-usa.com USA Overview All G has announced the launch of bovine-free lactoferrin in the U.S. market, produced using precision fermentation technology, with human-identical protein launch imminent. The company has partnered wi... -
Fujifilm Prepares for Patent Cliff with Strategic CDMO Investments; Samsung Biologics Acquires PolyPeptide for $1.8B, Entering Peptide Market
Endpoints News Global Overview The pharmaceutical industry faces a 'patent cliff' with ~$300 billion in branded drug revenues at risk from 2025-2030, driving active deals for portfolio expansion and cost efficiency. Contract Development ... -
Repligen Acquires BioLife Solutions for ~$1.5B, Expanding Cell Therapy Services; Beone Medicines Invests $300M in US Manufacturing Expansion
Endpoints News USA Overview Repligen has announced the acquisition of cell processing service provider BioLife Solutions for approximately $1.5 billion, significantly broadening its capabilities within the cell therapy sector. Concurrent... -
Precision Fermentation Drives Next-Gen Food Innovation: MycoTechnology Unveils Honey Truffle Sweet Protein, All G Launches Cow-Free Lactoferrin in US
foodingredientsfirst.com / Precision Fermentation News / flavorist.com / Vivici / Microbio International Overview Precision fermentation is significantly advancing the next-generation food ingredient market. MycoTechnology announced its ... -
Cultivated Meat Regulation Matures Globally: US Federal Approvals, ANZ Standards, and UK Guidance Set New Benchmarks
Dr. Mercola International Overview The global regulatory environment for cultivated meat is rapidly advancing, with five products completing federal review in the US, alongside new cell-cultivated food standards in Australia/New Zealand ... -
AGC Biologics Secures Landmark Multi-Hundred-Million-Dollar Deal for Yokohama Facility, Cementing Japan’s Biologics Manufacturing Leadership
AGC Biologics Japan Overview AGC Biologics has secured a multi-year, multi-hundred-million-dollar commercial manufacturing agreement for its new Yokohama facility, slated to open in 2027. This landmark deal dedicates approximately half o... -
Reusable Bioreactor Market Surges: Driven by Large-Volume Biologics Production and CDMO Capacity Expansion, Hybrid Manufacturing Emerges
Constancy Researchers USA Overview The reusable bioreactor market is experiencing substantial growth, propelled by the increasing demand for large-volume commercial biopharmaceutical production and the expansion of CDMO capacities. A not...
